Cite
HARVARD Citation
Ozturk, Z. et al. (n.d.). Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress. Free radical research. pp. 309-316. [Online].